UPMC Physician Resources

Take the CME Evaluation

Parkinson’s Disease: Initial Diagnosis, Initial Treatment & Non-motor Features

Dr. J. Timothy Greenamyre provides an overview of Parkinson’s disease from the standpoint of how it is diagnosed on a day to day basis, how treatment begins, and reviews some of the non-motor features of the disease.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Review diagnosis of Parkinson’s Disease
  • Discuss nonmotor symptoms
  • Discuss treatment options and side effects

Reading Resources:

  1. Jain S, Siegle GJ, Gu C, Moore CG, Ivanco LS, Studenski S, Greenamyre JT, Steinhauer SR. Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease. Mov Disord. 2011 Jun;26(7):1344-7. doi: 10.1002/mds.23628.
  2. Lee JW, Tapias V, Di Maio R, Greenamyre JT, Cannon JR. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats. Neurobiol Aging. 2015 Jan;36(1):505-18. doi: 10.1016/j.neurobiolaging.2014.07.011.
  3. Schapira AH, Olanow CW, Greenamyre JT, Bezard E. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet. 2014 Aug 9;384(9942):545-55. doi: 10.1016/S0140-6736(14)61010-2. Review.

Disclosures:

Dr. Greenamyre has financial interests with the following proprietary entity or entities producing health care goods or services as indicated below:

  • Grant/Research Support: Biogen, Sanofi
  • Consultant: Pfizer

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to .5 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

ABIM MOC Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.  

To receive your ABIM MOC Part 2 credit, you will need to complete the post-test and evaluation process and provided your date of birth and ABIM number, along with the other required fields.

 

Release Date: 2/15/2017 | Last Modified On: 2/15/2017 | Expires: 2/10/2020

TRANSCRIPT

Presenter

J. Timothy Greenamyre, MD, PhD

J. Timothy Greenamyre, MD, PhD Professor of Neurology
Chief, Movement Disorders Division
Director, Pittsburgh Institute for Neurodegenerative Diseases (PIND)
Phone: (412) 692-4920
View Full Profile